TechNavio's analysts forecast the Global Facial Injectable market to grow at a CAGR of 8.5 percent over the period 2011-2015. One of the key factors contributing to this market growth is increasing incidents of HIV-associated Lipodystrophy in the US. The Global Facial Injectable market has also been witnessing an increase in new product launches. However, side effects of dermal fillers could pose a challenge to the growth of this market.

TechNavio's report, Global Facial Injectable Market 2011-2015, has been prepared based on an in-depth analysis of the market with inputs from industry experts. The report covers the Americas and the EMEA and APAC regions; it also covers the Global Facial Injectable market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors dominating this market space include Allergan Inc., Galderma S.A., Merz Pharma GmbH Co. KGaA, Ipsen S.A., and Sanofi S.A.

Key questions answered in this report:
What will the market size be in 2014 and at what rate will it grow?
What key trends is this market subject to?
What is driving this market?
What are the challenges to market growth?
Who are the key vendors in this market space?
What are the opportunities and threats faced by each of these key vendors?
What are the strengths and weaknesses of each of these key vendors?

You can request one free hour of analyst time when you purchase this report. Details provided within the report.